Omega Healthcare Investors (OHI) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Omega Healthcare Investors (OHI) reported $311.59 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 12.9%. EPS of $0.79 for the same period compares to $0.42 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $308.6 million, representing a surprise of +0.97%. The company delivered an EPS surprise of +2.6%, with the consensus EPS estimate being $0.77.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.Here is how Omega Healthcare Investors performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:Revenues- Rental income: $260.74 million versus $262.17 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a +14.5% change.Revenues- Real estate tax and ground lease income: $3.8 million compared to the $3.62 million average estimate based on two analysts. The reported number represents a change of +2.3% year over year.Diluted- Net income (loss): $0.59 versus the two-analyst average estimate of $0.44.View all Key Company Metrics for Omega Healthcare Investors here>>>Shares of Omega Healthcare Investors have returned -6.6% over the past month versus the Zacks S&P 500 composite's +3.6% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.Zacks' Research Chief Picks Stock Most Likely to "At Least Double"Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.See Our Top Stock to Double (Plus 4 Runners Up) >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Omega Healthcare Investors, Inc. (OHI): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks